Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Opioids on Heart Rate During Rapid Sequence Intubation
NCT05384665Terminated
- Sponsor
- Centre Hospitalier Sud Francilien
- Start
- May 2023
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in rapid sequence induction (RSI) comparing Group A (placebo + remifentanil), Group B (sufentanil + placebo) and Group C (placebo + placebo) (3 arms). Primary endpoint: Heart Rate. Started May 2023; status: terminated.
02
Drugs
remifentanilsufentanil
03
Conditions
rapid sequence induction (RSI)
Beyond the preview
Go deeper on NCT05384665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05384665.